Manuela Ferracin
- Cancer Research top 0.01%
- MicroRNA in disease regulation 85
- Cancer-related molecular mechanisms research 51
- Molecular Biology top 0.05%
- Circular RNAs in diseases 42
- RNA modifications and cancer 21
- Extracellular vesicles in disease 21
- RNA Interference and Gene Delivery 13
- Advanced biosensing and bioanalysis techniques 8
- Genetics top 0.5%
- Immunology top 1%
- Oncology top 1%
- Cutaneous Melanoma Detection and Management 8
- Co-authors
- Massimo NegriniCarlo M. CroceGeorge A. CalinChang‐Gong LiuStefano VoliniaMarilena V. IorioAmelia CimminoAngelo Veronese
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Manuela Ferracin
155 papers receiving 24.4k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Cancer Research 18.7k
- Molecular Biology 19.8k
- Genetics 1.1k
- Immunology 1.8k
- Oncology 1.9k
Countries citing papers authored by Manuela Ferracin
This map shows the geographic impact of Manuela Ferracin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuela Ferracin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuela Ferracin more than expected).
Fields of papers citing papers by Manuela Ferracin
This network shows the impact of papers produced by Manuela Ferracin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuela Ferracin. The network helps show where Manuela Ferracin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Manuela Ferracin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 26 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 26 | |
| 6 | 2020 | 50 | |
| 7 | 2019 | 45 | |
| 8 | 2019 | 50 | |
| 9 | 2016 | 17 | |
| 10 | 2014 | 74 | |
| 11 | 2014 | 51 | |
| 12 | 2010 | 182 | |
| 13 | 2009 | 261 | |
| 14 | 2009 | 343 | |
| 15 | Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinomabreakdown → | 2007 | 670 |
| 16 | 2007 | 13 | |
| 17 | A microRNA expression signature of human solid tumors defines cancer gene targetsbreakdown → | 2006 | 4730 |
| 18 | A MicroRNA Signature of Hypoxiabreakdown → | 2006 | 890 |
| 19 | miR-15 and miR-16 induce apoptosis by targeting BCL2breakdown → | 2005 | 2787 |
| 20 | MicroRNA Gene Expression Deregulation in Human Breast Cancerbreakdown → | 2005 | 3320 |
About Manuela Ferracin
Manuela Ferracin is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 161 papers that have together received 24.8k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (85 papers), Cancer-related molecular mechanisms research (51 papers), Circular RNAs in diseases (42 papers), RNA modifications and cancer (21 papers), Extracellular vesicles in disease (21 papers), RNA Interference and Gene Delivery (13 papers), Cutaneous Melanoma Detection and Management (8 papers) and Advanced biosensing and bioanalysis techniques (8 papers). The work is most often cited by research in Cancer Research (18.7k citations), Molecular Biology (19.8k citations) and Genetics (1.1k citations). Manuela Ferracin has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Massimo Negrini, Carlo M. Croce, George A. Calin, Chang‐Gong Liu, Stefano Volinia, Marilena V. Iorio, Amelia Cimmino, Angelo Veronese, Hansjüerg Alder and Silvia Sabbioni.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.